Oxidized Regenerated Cellulose and Voice Quality After Total Thyroidectomy
NCT: NCT07681557 · COMPLETED
Brief Summary
This randomized controlled trial evaluated whether placement of oxidized regenerated cellulose (ORC) over the recurrent laryngeal nerves during total thyroidectomy affects early postoperative voice quality. Patients undergoing bilateral total thyroidectomy for benign or malignant thyroid disease were assigned in a 1:1 ratio to bilateral placement of ORC within the thyroid bed or to conventional hemostasis without ORC. All participants underwent preoperative videolaryngostroboscopic examination and objective acoustic voice analysis. Acoustic assessment was repeated on postoperative day 21. The study evaluated changes in jitter, shimmer, normalized noise energy, harmonics-to-noise ratio, maximum phonation time, and the s/z ratio. Postoperative complications and adverse events potentially related to ORC were also recorded.
Frequently Asked Questions
What is Oxidized Regenerated Cellulose and Voice Quality After Total Thyroidectomy?
Oxidized Regenerated Cellulose and Voice Quality After Total Thyroidectomy is a clinical trial registered under NCT07681557. Current status: COMPLETED.
What is the status of NCT07681557?
The current status of NCT07681557 (Oxidized Regenerated Cellulose and Voice Quality After Total Thyroidectomy) is: COMPLETED.
When did Oxidized Regenerated Cellulose and Voice Quality After Total Thyroidectomy start?
Oxidized Regenerated Cellulose and Voice Quality After Total Thyroidectomy started on 2014-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.